Ascentage Pharma Group International
Ascentage Pharma's GHG Emissions Data Preview
In 2023, Ascentage Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).
Ascentage Pharma has also provided a category-level breakdown for 5 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Ascentage Pharma's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Ascentage Pharma amounted to 7,776.66 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Ascentage Pharma increased by 43.8%, suggesting that the company faced challenges in reducing its emissions from its core operations.
Ascentage Pharma's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Ascentage Pharma's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Ascentage Pharma were 2,081.23 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Ascentage Pharma reduced its Scope 1 emissions over time?
Since 2021, Ascentage Pharma's Scope 1 emissions have increased by 27,034.68%, reflecting a rising long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), Ascentage Pharma's Scope 1 emissions increased by 56.6%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
What are Ascentage Pharma's Scope 2 emissions?
In 2023, Ascentage Pharma reported Scope 2 greenhouse gas (GHG) emissions of 5,695.43 tCOâ‚‚e without specifying the calculation method.
Has Ascentage Pharma reduced its Scope 2 emissions over time?
Since 2021, Ascentage Pharma's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 509.51%, reflecting a rising long-term trend in Scope 2 emissions over time.
Compared to the previous year (2022), Ascentage Pharma's Scope 2 emissions (Unspecified Calculation Method) rose by 39.63% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy
What methodology does Ascentage Pharma use for Scope 2 reporting?
In 2023, Ascentage Pharma reported its Scope 2 emissions using an unspecified methodology.
Ascentage Pharma's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Ascentage Pharma's Value Chain Emissions
In 2023, Ascentage Pharma reported 1,309.53 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.
The 2023 disclosure of Ascentage Pharma includes a breakdown across 5 of the 15 Scope 3 categories defined by the GHG Protocol, up from 0 in 2022, reflecting improved emissions accounting practices and greater transparency across the company's value chain
Ascentage Pharma's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Ascentage Pharma's Scope 3 emissions?
In 2023, Ascentage Pharma reported total Scope 3 emissions of 1,309.53 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment.
What categories of Scope 3 emissions does Ascentage Pharma disclose?
In 2023, Ascentage Pharma reported emissions for 5 out of the 15 Scope 3 categories defined by the GHG Protocol.
This partial disclosure allows for some insight into the company's indirect impacts.
What are the main sources of Ascentage Pharma's Scope 3 emissions?
In 2023, the largest contributors to Ascentage Pharma's Scope 3 emissions were:
- Business Travel (Cat. 6): 1,008 tCOâ‚‚e (76.97%)
- Employee Commuting (Cat. 7): 188.72 tCOâ‚‚e (14.41%)
- Purchased Goods and Services (Cat. 1): 112.18 tCOâ‚‚e (8.57%)
Ascentage Pharma's Scope 3 Emissions by Categories
Insights into Ascentage Pharma's Total Carbon Footprint
In 2023, Ascentage Pharma reported a total carbon footprint of 9,086.19 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 68.01% increase compared to 2022, suggesting a rise in emissions across its operations or value chain.
The largest contributor to Ascentage Pharma's total carbon footprint was Scope 2 emissions, accounting for 62.68% of the company's total carbon footprint, followed by Scope 1 emissions at 22.91%.